Net Loss Per Share - Schedule of Potential Shares of Common Stock Excluded from Computation of Diluted Net Loss Per Share (Details) - shares |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||
| Total antidilutive securities (in shares) | 11,297,047 | 12,436,850 |
| Stock options | ||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||
| Total antidilutive securities (in shares) | 5,241,756 | 6,604,136 |
| Restricted stock units | ||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||
| Total antidilutive securities (in shares) | 5,262,090 | 5,342,012 |
| Performance stock units | ||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||
| Total antidilutive securities (in shares) | 717,122 | 413,568 |
| ESPP purchase rights | ||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||
| Total antidilutive securities (in shares) | 76,079 | 77,134 |